Identification | Back Directory | [Name]
1-BOC-4-FLUORO-4-(HYDROXYMETHYL)-PIPERIDINE | [CAS]
614730-97-1 | [Synonyms]
1-Boc-4-fluoro-4-(hydroxy... 1-BOC-4-FLUORO-4-(HYDROXYMETHYL)-PIPERIDINE tert-butyl 4-fluoro-4-(hydroxymethyl)piperidine-1-carboxylate tert-Butyl 4-fluoro-4-(hydroxymethyl)piperidine-1-carboxylate 97% 4-fluoro-4-hydroxymethyl-piperidine-1-carboxylic acid tert-butyl ester 1-PIPERIDINECARBOXYLIC ACID, 4-FLUORO-4-(HYDROXYMETHYL)-, 1,1-DIMETHYLETHYL ESTER | [Molecular Formula]
C11H20FNO3 | [MDL Number]
MFCD08062513 | [MOL File]
614730-97-1.mol | [Molecular Weight]
233.28 |
Chemical Properties | Back Directory | [Boiling point ]
311.0±27.0 °C(Predicted) | [density ]
1.13±0.1 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,2-8°C | [pka]
14.94±0.10(Predicted) | [Appearance]
Colorless to off-white Solid-Liquid Mixture | [InChI]
InChI=1S/C11H20FNO3/c1-10(2,3)16-9(15)13-6-4-11(12,8-14)5-7-13/h14H,4-8H2,1-3H3 | [InChIKey]
BWZOULIMVKCGII-UHFFFAOYSA-N | [SMILES]
N1(C(OC(C)(C)C)=O)CCC(F)(CO)CC1 |
Hazard Information | Back Directory | [Uses]
tert-Butyl 4-Fluoro-4-(hydroxymethyl)piperidine-1-carboxylate is used in preparation of heterocyclic compounds as BCL 2 inhibitors. | [Synthesis]
General procedure for the synthesis of 1-Boc-4-fluoro-4-(hydroxymethyl)piperidine from 1-oxa-6-azaspiro[2.5]octane-6-carboxylic acid tert-butyl ester: Commercially available epoxide (2 g, 9.38 mmol) was dissolved in 10 mL of dichloromethane, and added slowly and dropwise to a pre-cooled to -10°C 0.6 mL solution of HF pyridinium fluoride (70%) in a 10 mL dichloromethane to a mixture of 0.6 mL HF pyridinium fluoride (70%) and 10 mL methylene chloride. The reaction mixture was kept at -10°C. After the dropwise addition was completed, the reaction system was warmed to room temperature and stirred continuously for 4 hours. Upon completion of the reaction, the reaction mixture was diluted with dichloromethane and subsequently washed with saturated aqueous sodium carbonate solution. The organic phase was separated, dried with anhydrous sodium sulfate, filtered and concentrated under reduced pressure to remove the solvent to give the crude product. Purification by silica gel column chromatography with ethyl acetate/heptane (20% to 50%) as eluent afforded 1-Boc-4-fluoro-4-(hydroxymethyl)piperidine as a pale yellow oil (1.44 g, 66% yield).1H-NMR (400 MHz, CDCl3) data: δ=1.44 (s, 9H), 1.47-1.63 (m, 2H). 1.85 (m, 2H), 3.08 (m, 2H), 3.56 (s, 1H), 3.61 (s, 1H), 3.92 (brs, 2H). ms ESI: m/z=233.98 (M+). | [References]
[1] Patent: US2011/256064, 2011, A1. Location in patent: Page/Page column 19; 20 [2] Patent: EP2377860, 2011, A1. Location in patent: Page/Page column 26 [3] Patent: EP1505067, 2005, A1. Location in patent: Page/Page column 368; 369 [4] Journal of Medicinal Chemistry, 2008, vol. 51, # 13, p. 3692 - 3695 [5] Patent: WO2004/5255, 2004, A1. Location in patent: Page 26-27 |
|
|